Gastroenterologists are uniquely positioned to expand their critical role in detecting and treating gastrointestinal diseases ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

New research from Virginia Tech’s Fralin Biomedical Research Institute shows that low-intensity electrical pulse ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

those whose cancer was responding to chemotherapy and had low volume peritoneal disease. So I think continuing to explore these different, what we call local therapy techniques, and integrating them ...

Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Preclinical data shows IL1 family signals mediate systemic immune suppression.Blocking IL1RAP can overcome resistance to immune therapy ...

If the European Commission approves this treatment, it'll be the first HER2-targeted agent for HER2-positive biliary tract cancer available to patients in the EU.